Tag: Schedule III

D.C. cannabis licensing setback for DC Dank, with the Board upholding the denial after finding the proposed shop too close to Miner Elementary School, while also tracking Virginia’s effort to gather industry feedback on future retail cannabis rules, Maryland’s hemp lawsuit developments, and other Mid-Atlantic cannabis policy changes affecting operators and investors.

D.C. weed dispensaries are preparing for incoming competition as Virginia sets a July 2027 launch date for recreational sales. Plus, the state moves to close its 25:1 hemp loophole by August 15, Maryland launches its “Open Roads” B2B social equity tour, and top lobbyist Bruce Bereano lands a major cannabis trade client.

D.C. sets new records for medical cannabis sales and patient registrations, Virginia establishes a framework for adult-use sales starting in 2027, Maryland responds to DEA inspection reports, and the DEA begins its landmark marijuana rescheduling hearing, alongside key enforcement, research, and industry developments from across the country.

This week’s roundup covers a July hearing on three D.C. medical cannabis bills, the closure of three more illicit cannabis stores in the District, growing backlash to Virginia’s cannabis compromise, a major cannabis seizure in Baltimore and the Supreme Court’s unanimous ruling against the federal gun ban for cannabis users. Plus, updates on DEA rescheduling…

A unanimous Supreme Court ruling that the federal government cannot strip cannabis users of their Second Amendment rights, and Virginia’s long-awaited breakthrough on a regulated adult-use cannabis market set to launch in July 2027. On the D.C. front, regulators are moving to deny a retail license for Aloha over alleged illegal activity, while Baltimore authorities…

Plus Maryland ramps up enforcement against illicit smoke shops, and industry consolidation and regulatory updates continue across the region.

A D.C. zoning technicality clears a dispensary’s path while exposing a gap in the District’s cannabis buffer law. Plus: a Boston hedge fund now controls 40% of Virginia’s medical market, three GOP attorneys general sue to block rescheduling, and Jushi becomes one of the first MSOs to apply for DEA registration under the new Schedule…